Cantitate/Preț
Produs

Behavioral Neurobiology of Psychedelic Drugs: Current Topics in Behavioral Neurosciences, cartea 36

Editat de Adam L. Halberstadt, Franz X. Vollenweider, David E. Nichols
en Limba Engleză Hardback – 11 apr 2018
This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs. Examples of drugs within this group include LSD, psilocybin, and mescaline. Despite their structural differences, these compounds produce remarkably similar experiences in humans and share a common mechanism of action.  Commonalities among the substances in this family are addressed both at the clinical and phenomenological level and at the basic neurobiological mechanism level. To the extent possible, contributions relate the clinical and preclinical findings to one another across species. The volume addresses both the risks associated with the use of these drugs and the potential medical benefits that might be associated with these and related compounds.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 108081 lei  39-44 zile
  Springer Berlin, Heidelberg – 19 ian 2019 108081 lei  39-44 zile
Hardback (1) 108605 lei  39-44 zile
  Springer Berlin, Heidelberg – 11 apr 2018 108605 lei  39-44 zile

Din seria Current Topics in Behavioral Neurosciences

Preț: 108605 lei

Preț vechi: 142901 lei
-24%

Puncte Express: 1629

Preț estimativ în valută:
20807 22590$ 17844£

Carte tipărită la comandă

Livrare economică 06-11 mai

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783662558782
ISBN-10: 3662558785
Pagini: 430
Ilustrații: X, 430 p. 196 illus., 158 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.77 kg
Ediția:1st ed. 2018
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Current Topics in Behavioral Neurosciences

Locul publicării:Berlin, Heidelberg, Germany

Cuprins

Preface.- Chemistry and structure-activity relationships of psychedelics.- Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways.- Effects of hallucinogens on neuronal activity.- Interactions of Hallucinogens with the Glutamatergic System:  Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons.- The effects of hallucinogens on gene expression.- Effect of Hallucinogens on Unconditioned Behavior.- Hallucinogens in Drug Discrimination.- Phenomenology, structure and dynamic of psychedelic states.- Serotonergic hallucinogen-induced visual perceptual alterations.- New world tryptamine hallucinogens and the neuroscience of ayahuasca.- Experimental psychosis research and schizophrenia - similarities and dissimilarities in psychopathology.- A review of Hallucinogen Persisting Perception Disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD.- Therapeutic applications of classic hallucinogens.- Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.

Recenzii

“This book brings together the latest basic and clinical research into the underlying mechanism of action, effects, and possible clinical uses of psychedelic drugs. … It brings together current knowledge regarding this class of drugs pharmacology, neurobiological effects, subjective experience, and therapeutic effects. … It brings together preclinical and clinical data, which will be of interest to anyone involved with or curious about this category of drugs.” (Michael Easton, Doody's Book Reviews, September, 2018)

Textul de pe ultima copertă

This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs. Examples of drugs within this group include LSD, psilocybin, and mescaline. Despite their structural differences, these compounds produce remarkably similar experiences in humans and share a common mechanism of action.  Commonalities among the substances in this family are addressed both at the clinical and phenomenological level and at the basic neurobiological mechanism level. To the extent possible, contributions relate the clinical and preclinical findings to one another across species. The volume addresses both the risks associated with the use of these drugs and the potential medical benefits that might be associated with these and related compounds.

Caracteristici

The volume brings together clinical and preclinical research literatures
A balanced view of the potential risks and benefits of these compounds is presented
The focus is on rigorous scientific findings in a field that has been fraught with speculative reports